• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

相似文献

1
Immunogenicity of BNT162b2 SARS-CoV-2 Vaccine in a Multicenter Cohort of Nursing Home Residents Receiving Maintenance Hemodialysis.BNT162b2新型冠状病毒疫苗在接受维持性血液透析的养老院居民多中心队列中的免疫原性
Am J Kidney Dis. 2021 Nov;78(5):766-768. doi: 10.1053/j.ajkd.2021.07.004. Epub 2021 Aug 6.
2
Immunogenicity of COVID-19 Tozinameran Vaccination in Patients on Chronic Dialysis.慢性透析患者 COVID-19 疫苗接种的免疫原性。
Front Immunol. 2021 Jun 30;12:690698. doi: 10.3389/fimmu.2021.690698. eCollection 2021.
3
COVID-19 vaccine breakthrough infections.COVID-19 疫苗突破性感染。
Science. 2021 Dec 24;374(6575):1561-1562. doi: 10.1126/science.abl8487. Epub 2021 Dec 23.
4
An analysis of antibody responses and clinical sequalae of the Sinopharm HB02 COVID19 vaccine in dialysis patients in the United Arab Emirates.在阿拉伯联合酋长国，对接受透析治疗的患者接种国药控股 HB02 新冠疫苗后的抗体反应和临床后遗症进行分析。
Nephrology (Carlton). 2022 Mar;27(3):260-268. doi: 10.1111/nep.13980. Epub 2021 Oct 5.
5
Early antibody response in health-care professionals after two doses of SARS-CoV-2 mRNA vaccine (BNT162b2).医护人员接种两剂 SARS-CoV-2 mRNA 疫苗（BNT162b2）后的早期抗体反应。
Clin Microbiol Infect. 2021 Sep;27(9):1351.e5-1351.e7. doi: 10.1016/j.cmi.2021.05.004. Epub 2021 May 8.
6
Immunogenicity of the BNT162b2 COVID-19 mRNA vaccine and early clinical outcomes in patients with haematological malignancies in Lithuania: a national prospective cohort study.立陶宛血液系统恶性肿瘤患者的 BNT162b2 COVID-19 mRNA 疫苗免疫原性和早期临床结局：一项全国前瞻性队列研究。
Lancet Haematol. 2021 Aug;8(8):e583-e592. doi: 10.1016/S2352-3026(21)00169-1. Epub 2021 Jul 2.
7
Short-term antibody response after 1 dose of BNT162b2 vaccine in patients receiving hemodialysis.接受血液透析患者接种 1 剂 BNT162b2 疫苗后的短期抗体反应。
CMAJ. 2021 May 31;193(22):E793-E800. doi: 10.1503/cmaj.210673. Epub 2021 May 12.
8
Measuring cellular and humoral immunogenicity of a SARS-CoV-2 mRNA vaccine (BNT126b2) in patients on maintenance haemodialysis.评估严重急性呼吸综合征冠状病毒2（SARS-CoV-2）信使核糖核酸（mRNA）疫苗（BNT126b2）在维持性血液透析患者中的细胞免疫原性和体液免疫原性。
EBioMedicine. 2021 Sep;71:103567. doi: 10.1016/j.ebiom.2021.103567. Epub 2021 Aug 26.
9
Humoral response after SARS-CoV-2 mRNA vaccines in dialysis patients: Integrating anti-SARS-CoV-2 Spike-Protein-RBD antibody monitoring to manage dialysis centers in pandemic times.透析患者接种 SARS-CoV-2 mRNA 疫苗后的体液反应：整合抗 SARS-CoV-2 刺突蛋白-RBD 抗体监测以管理大流行期间的透析中心。
PLoS One. 2021 Oct 5;16(10):e0257646. doi: 10.1371/journal.pone.0257646. eCollection 2021.
10
A government-led effort to identify correlates of protection for COVID-19 vaccines.一项由政府主导的确定新冠疫苗保护相关因素的工作。
Nat Med. 2021 Sep;27(9):1493-1494. doi: 10.1038/s41591-021-01484-6.

引用本文的文献

1
Effectiveness and safety of immune response to SARS‑CoV‑2 vaccine in patients with chronic kidney disease and dialysis: A systematic review and meta‑analysis.慢性肾脏病及透析患者对SARS-CoV-2疫苗免疫反应的有效性和安全性：一项系统评价和荟萃分析
Biomed Rep. 2024 Mar 19;20(5):78. doi: 10.3892/br.2024.1766. eCollection 2024 May.
2
Vaccination for Patients Receiving Dialysis.接受透析患者的疫苗接种
Kidney Med. 2023 Dec 9;6(3):100775. doi: 10.1016/j.xkme.2023.100775. eCollection 2024 Mar.
3
Trajectory of Humoral Responses to Two Doses of ChAdOx1 nCoV-19 Vaccination in Patients Receiving Maintenance Hemodialysis.接受维持性血液透析的患者对两剂ChAdOx1 nCoV-19疫苗接种的体液免疫反应轨迹
Microbiol Spectr. 2023 Feb 21;11(2):e0344522. doi: 10.1128/spectrum.03445-22.
4
Outcomes of vaccinations against respiratory diseases in patients with end-stage renal disease undergoing hemodialysis: A systematic review and meta-analysis.终末期肾病血液透析患者接种呼吸道疾病疫苗的效果：系统评价和荟萃分析。
PLoS One. 2023 Feb 9;18(2):e0281160. doi: 10.1371/journal.pone.0281160. eCollection 2023.
5
Immunogenicity and safety of SARS-CoV-2 vaccine in hemodialysis patients: A systematic review and meta-analysis.血液透析患者中 SARS-CoV-2 疫苗的免疫原性和安全性：系统评价和荟萃分析。
Front Public Health. 2022 Sep 23;10:951096. doi: 10.3389/fpubh.2022.951096. eCollection 2022.
6
Immunogenicity of COVID-19 mRNA vaccines in hemodialysis patients: Systematic review and meta-analysis.新冠病毒mRNA疫苗在血液透析患者中的免疫原性：系统评价与荟萃分析
Health Sci Rep. 2022 Oct 3;5(6):e874. doi: 10.1002/hsr2.874. eCollection 2022 Nov.
7
Decline of Humoral Responses 6 Months after Vaccination with BNT162b2 (Pfizer-BioNTech) in Patients on Hemodialysis.血液透析患者接种BNT162b2（辉瑞-生物科技公司）疫苗6个月后体液免疫反应的下降情况。
Vaccines (Basel). 2022 Feb 18;10(2):327. doi: 10.3390/vaccines10020327.
8
Immunosuppression and SARS-CoV-2 Infection in Kidney Transplant Recipients.肾移植受者的免疫抑制与新冠病毒感染
Transplant Direct. 2022 Feb 10;8(3):e1292. doi: 10.1097/TXD.0000000000001292. eCollection 2022 Mar.
9
Humoral responses to BNT162b2 SARS-CoV-2 and hepatitis B vaccines are associated in patients on maintenance hemodialysis: a single-centre experience in Belgium.维持性血液透析患者对BNT162b2新冠疫苗和乙肝疫苗的体液免疫反应存在关联：比利时的一项单中心经验
Clin Kidney J. 2021 Nov 11;15(2):363-365. doi: 10.1093/ckj/sfab221. eCollection 2022 Feb.
10
Immunological and clinical efficacy of COVID-19 vaccines in immunocompromised populations: a systematic review.新冠病毒疫苗在免疫功能低下人群中的免疫和临床疗效：一项系统评价
Clin Microbiol Infect. 2022 Feb;28(2):163-177. doi: 10.1016/j.cmi.2021.09.036. Epub 2021 Nov 17.

Immunogenicity of BNT162b2 SARS-CoV-2 Vaccine in a Multicenter Cohort of Nursing Home Residents Receiving Maintenance Hemodialysis.

作者信息

Labriola Laura, Scohy Anaïs, Van Regemorter Elliott, Robert Arnaud, Clerbaux Gaëtan, Gillerot Gaelle, Pochet Jean-Michel, Biller Pauline, De Schuiteneer Manuel, Morelle Johann, Yombi Jean Cyr, Kabamba Benoît, Rodriguez-Villalobos Hector, Jadoul Michel

机构信息

Division of Nephrology, Cliniques Universitaires Saint-Luc, Université catholique de Louvain, Brussels, Belgium; Institut de Recherche Expérimentale et Clinique (IREC), Université catholique de Louvain, Brussels, Belgium.

Division of Microbiology, Cliniques Universitaires Saint-Luc, Université catholique de Louvain, Brussels, Belgium; Institut de Recherche Expérimentale et Clinique (IREC), Université catholique de Louvain, Brussels, Belgium.

出版信息

Am J Kidney Dis. 2021 Nov;78(5):766-768. doi: 10.1053/j.ajkd.2021.07.004. Epub 2021 Aug 6.

DOI:10.1053/j.ajkd.2021.07.004
PMID:34364905
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8342865/
Abstract
摘要